microdosing glp 1 for longevity GLP-1s: Does It Work? Risks and Benefits Unlocking Longevity with GLP-1: A

Description

On 29 January 2026, the MHRA updated product information for GLP-1s and issued a drug safety alert to highlight that acute pancreatitis is a known but infrequent side effect that can be fatal, stressing that patients and clinicians should be alert to initial symptoms, such as severe, persistent stomach pain that may radiate to the back and may be accompanied by nausea and vomiting 26

Here is what caught researchers off guard: liraglutide, dulaglutide, and exenatide showed no statistically significant increase in hair loss reports at all

This compared with the 61% reduction reported in clinical trials for nalmefene a medication approved by the European Medicines Agency for reduction of alcohol consumption

Stenberg E, Nslund E (2023) Major adverse cardiovascular events among patients with type-2 diabetes, a nationwide cohort study comparing primary metabolic and bariatric surgery to GLP-1 receptor agonist treatment